0.74%| Prev Close: | 0.20 |
|---|---|
| Open: | 0.20 |
| Bid: | 0.20 x 8000 |
| Ask: | 0.23 x 4500 |
| 1y Target Est: | N/A |
| Beta: | 1.97 |
| Next Earnings Date: | N/A |
| Day's Range: | 0.20 - 0.21 |
|---|---|
| 52wk Range: | 0.18 - 1.10 |
| Volume: | 322,393 |
| Avg Vol (3m): | 531,292 |
| Market Cap: | 33.53M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.13 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- HEMISPHERX BIOPHARMA INC FinancialsEDGAR Online Financials(Tue May 14)
- Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013GlobeNewswire(Wed May 8)
- HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed May 8)
- The 5 Dumbest Things on Wall Street This Week: May 3at TheStreet(Fri May 3)
- [video] 5 Dumbest Things on Wall Streetat TheStreet(Fri May 3)
- An Outrageous, Shameless Act by Hemispherx's Board of Directorsat TheStreet(Wed May 1)
- Biotechs Ramping Up On China's Avian Flu Outbreakat Seeking Alpha(Mon Apr 8)
- Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012GlobeNewswire(Mon Mar 18)
- HEMISPHERX BIOPHARMA INC Files SEC form 10-K, Annual ReportEDGAR Online(Mon Mar 18)
- Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in ArgentinaGlobeNewswire(Mon Mar 4)
- U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year PreviousMarketwired(Fri Mar 1)
- UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hemispherx Biopharma, Inc. of Class Action Lawsuit and the Deadline of February 22, 2013 to Seek a Lead Plaintiff PositionBusiness Wire(Wed Feb 20)
- Hunger strike ends with promise to address chronic lack of fatigue drugsat bizjournals.com(Mon Feb 11)
- New NSU institute seeks treatments for chronic fatigue syndrome, Gulf War Illnessat bizjournals.com(Mon Feb 11)
- ShinesRooms Research on Gilead and Hemispherx: Biotech Companies Seek New PasturesAccesswire(Fri Feb 8)
Press Releases
- ShinesRooms Research on Gilead and Hemispherx: Biotech Companies Seek New PasturesAccesswire(Fri Feb 8)
- Ubika Research’s Daily US Box Score: Top Junior Technology (NASDAQ GM: MERU) Stock Gained 42%Accesswire(Thu Jan 31)
- Ubika Research’s daily U.S. Box Score: Top Junior Financial stock (NASDAQ: HGSH) Gained 175%Accesswire(Thu Nov 1)
Must Read
- Gap's 1st-quarter net income rises 43 per cent on strong sales as turnaround continuesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Marathon Oil: talks tied to sale of part of stake in Athabasca Oil Project have endedThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TD Bank looking for cost savings amid continued low interest ratesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Loonie heads higher despite disappointing Chinese manufacturing dataThe Canadian Press(1969-12-31T18:59:59GMT-05:00)